Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
13.81
+0.14 (1.02%)
At close: Feb 2, 2026, 4:00 PM EST
13.81
0.00 (0.00%)
After-hours: Feb 2, 2026, 4:32 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Vonoprazan
55.25M
Vonoprazan Growth
8001.47%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
55.25M
United States Growth
8001.47%